Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury - Insights from cardiovascular magnetic resonance imaging

被引:326
作者
Selvanayagam, JB
Porto, I
Channon, K
Petersen, SE
Francis, JM
Neubauer, S
Banning, AP [1 ]
机构
[1] John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England
[2] Univ Oxford, Ctr Clin Magnet Resonance Res, Dept Cardiovasc Med, Oxford OX1 2JD, England
关键词
magnetic resonance imaging; myocardial infarction; angioplasty; stents;
D O I
10.1161/01.CIR.0000156328.28485.AD
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Although troponin elevation after percutaneous coronary intervention (PCI) is common, uncertainties remain about the mechanisms of its release and its relationship to the volume of myocardial tissue loss. Delayed-enhancement MRI of the heart has been shown to reliably quantify areas of irreversible myocardial injury. To investigate the quantitative relationship between irreversible injury and cardiac troponin release, we studied the incidence and extent of new irreversible injury in patients undergoing PCI and correlated it to postprocedural changes in cardiac troponin I. Methods and Results - Fifty patients undergoing PCI were studied with preprocedural and postprocedural (24 hours) delayed-enhancement MRI for assessment of new irreversible myocardial injury. Cardiac troponin I measurements were obtained before PCI and 24 hours after PCI. Of these 50 patients, 24 underwent a further third MRI scan at a median of 8 months after the procedure. Mean patient age was 64 +/- 12 years. After the procedure, 14 patients (28%) had evidence of new myocardial hyperenhancement, with a mean mass of 6.0 +/- 5.8 g, or 5.0 +/- 4.8% of total left ventricular mass. All of these patients had raised troponin I levels ( range 1.0 to 9.4 mug/L). Thirty-four patients (68%) had no elevated troponin I and no evidence of new myocardial necrosis on MRI. There was a strong correlation between the rise in troponin I measurements at 24 hours and mean mass of new myocardial hyperenhancement, both early (r = 0.84; P < 0.001) and late (r = 0.71; P < 0.001) after PCI, although there was a trend for a reduction in the size of PCI-induced myocardial injury in the late follow-up scan (P = 0.07). Conclusions - In the setting of PCI, patients demonstrating postprocedural elevation in troponin I have evidence of new irreversible myocardial injury on delayed-enhancement MRI. The magnitude of this injury correlates directly with the extent of troponin elevation.
引用
收藏
页码:1027 / 1032
页数:6
相关论文
共 25 条
[1]   Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Alto, P ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
Van de Werf, F ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969
[2]   Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB [J].
Apple, FS .
CLINICA CHIMICA ACTA, 1999, 284 (02) :151-159
[3]  
Apple FS, 1997, CLIN CHEM, V43, P2047
[4]   Myonecrosis after revascularization procedures [J].
Califf, RM ;
Abdelmeguid, AE ;
Kuntz, RE ;
Popma, JJ ;
Davidson, CJ ;
Cohen, EA ;
Kleiman, NS ;
Mahaffey, KW ;
Topol, EJ ;
Pepine, CJ ;
Lipicky, RJ ;
Granger, CB ;
Harrington, RA ;
Tardiff, BE ;
Crenshaw, BS ;
Bauman, RP ;
Zuckerman, BD ;
Chaitman, BR ;
Bittl, JA ;
Ohman, EM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) :241-251
[5]   Prognostic significance of elevated troponin I after percutaneous coronary intervention [J].
Cantor, WJ ;
Newby, LK ;
Christenson, RH ;
Tuttle, RH ;
Hasselblad, V ;
Armstrong, PW ;
Moliterno, DJ ;
Califf, RM ;
Topol, EJ ;
Ohman, EM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (11) :1738-1744
[6]   Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction [J].
Ingkanisorn, WP ;
Rhoads, KL ;
Aletras, AH ;
Kellman, P ;
Arai, AE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :2253-2259
[7]   Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measurements [J].
Johansen, O ;
Brekke, M ;
Stromme, JH ;
Valen, V ;
Seljeflot, I ;
Skjaeggestad, O ;
Arnesen, H .
EUROPEAN HEART JOURNAL, 1998, 19 (01) :112-117
[8]   Comparison of Abbott AxSYM, Behring Opus Plus, DPC immulite and ortho-clinical diagnostics vitros ECi for measurement of cardiac troponin I [J].
Kao, JT ;
Wong, IL ;
Lee, JY ;
Chen, RC .
ANNALS OF CLINICAL BIOCHEMISTRY, 2001, 38 :140-146
[9]   Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction [J].
Kim, RJ ;
Chen, EL ;
Lima, JAC ;
Judd, RM .
CIRCULATION, 1996, 94 (12) :3318-3326
[10]  
McDonough JL, 2001, CIRCULATION, V103, P58